Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Vaccines01:30

Cancer Vaccines

396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethnic differences in skinfold thickness trajectories in children in the born in bradford 1000 cohort study provide modest support for the adipose tissue compartment hypothesis.

Diabetes & metabolic syndrome·2025
Same author

Supplementary inspired oxygen fraction is a simple clinical tool that predicts clinical deterioration.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

COLOFIT: Development and Internal-External Validation of Models Using Age, Sex, Faecal Immunochemical and Blood Tests to Optimise Diagnosis of Colorectal Cancer in Symptomatic Patients.

Alimentary pharmacology & therapeutics·2025
Same author

Pulse oximetry has limited utility in identifying potential patients for long-term oxygen therapy.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

The impact of urgency of umbilical hernia repair on adverse outcomes in patients with cirrhosis: a population-based cohort study from England.

Hernia : the journal of hernias and abdominal wall surgery·2023
Same author

Differential pulse oximetry readings between ethnic groups and delayed transfer to intensive care units.

QJM : monthly journal of the Association of Physicians·2022

Related Experiment Video

Updated: Jul 15, 2025

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Treatment of evolving cancers will require dynamic decision support.

M A R Strobl1, J Gallaher2, M Robertson-Tessi2

  • 1Integrated Mathematical Oncology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa; Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, USA.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|September 30, 2023
PubMed
Summary

Personalizing cancer drug dosing schedules is crucial for effective treatment. The proposed Adaptive Dosing Adjusted for Personalized Tumorscapes (ADAPT) paradigm uses mathematical modeling to tailor treatment to individual tumorscapes, moving beyond one-size-fits-all approaches.

Keywords:
cancer ecology and evolutionmathematical modelingtreatment scheduling

More Related Videos

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.4K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.4K

Related Experiment Videos

Last Updated: Jul 15, 2025

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.4K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.4K

Area of Science:

  • Oncology
  • Pharmacology
  • Mathematical Biology

Background:

  • Traditional cancer drug administration relies on fixed, maximum tolerated dose schedules.
  • This approach often fails to account for cancer's complexity, heterogeneity, and evolution.
  • Dynamic and personalized treatment strategies are needed to improve outcomes.

Purpose of the Study:

  • To highlight the importance of optimizing drug dose and frequency in cancer therapy.
  • To propose a novel framework for personalized cancer treatment scheduling.
  • To advocate for the integration of mathematical modeling in clinical practice.

Main Methods:

  • Reviewing historical milestones in cancer chemotherapy scheduling.
  • Introducing the five-step Adaptive Dosing Adjusted for Personalized Tumorscapes (ADAPT) paradigm.
  • Emphasizing the role of mathematical modeling in deriving personalized schedules.

Main Results:

  • Treatment response and failure are significantly influenced by drug scheduling.
  • Cancer heterogeneity and evolution necessitate individualized treatment strategies.
  • Model-guided personalization offers a promising avenue for optimizing therapy.

Conclusions:

  • A one-size-fits-all approach to cancer drug scheduling is inadequate.
  • The ADAPT paradigm provides a roadmap for dynamic, personalized treatment.
  • Further research and collaboration are needed to address challenges in data collection and model integration for clinical application.